CVS To Pay $75M For Admitted Sale Of Meth Ingredient
CVS Pharmacy Inc. on Thursday agreed to pay the federal government $75 million, admitting it sold pseudoephedrine, a key ingredient in methamphetamine, to criminals in violation of the Controlled Substances Act....To view the full article, register now.
Already a subscriber? Click here to view full article